
Heart failure is a major public health zzso Heart failure with preserved zzso function zzso is a common form, which is difficult to zzso zzso of recent studies show that zzso has a poor zzso with an annual survival rate similar to that of heart failure with left zzso zzso zzso Despite these findings, the therapeutic management of zzso is not clearly zzso We will discuss in this review of the literature the current therapeutic management of zzso including the role of zzso factors such as hypertension, zzso zzso and zzso zzso and the main results of zzso zzso and zzso controlled clinical trials in this zzso Only four large therapeutic trials have assessed the impact of different classes of drugs zzso zzso II converting zzso zzso zzso II receptors type I zzso and zzso on morbidity and mortality in zzso zzso of these trials are zzso Apart from the zzso the other three classes of drugs did not show benefit on the outcome of the zzso Moreover, the results of the zzso trial are controversial as a mixed population of heart failure with and without preserved zzso function was zzso Finally, the current therapeutic management of patients with zzso is still based on our zzso zzso education, low salt diet, zzso slowing heart rate and controlling triggering zzso Other large zzso controlled zzso trials, which may help us in the understanding of zzso and its therapeutic management, are zzso 

